CClinicalTrials.gg
CompletedNCT05768867FRAPEYQUESTUpdated Aug 27, 2024

French Translation and Validation of the PEYronie's Disease QUESTionnaire

An observational study in Peyronie Disease, sponsored by University Hospital, Toulouse. Completed at 1 site in France. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-08-27.

Sponsored by University Hospital, Toulouse · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
30
Ages
18 Years and older
Sex
Male
01

Study summary

This study is a prospective cohort dedicated to peyronie's disease. The aim is to validate the french translation of the peyronie's disease questionnaire. The primary endpoint is the response rate to the questionnaire.

02

Conditions studied

  • Peyronie Disease

Browse trials for

03

In context

Penile Induration

45 studies on the registry are indexed under Penile Induration; 10 are open to participants now.

Browse Penile Induration studies →

Lead sponsor

University Hospital, Toulouse is the lead sponsor of 794 studies on the registry; 214 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with Peyronie's Disease

Inclusion criteria

  • Adult patient with Peyronie's Disease clinically diagnosed during a consultation, with palpation of at least one plaque

Exclusion criteria

Exclusion Criteria:

  • Patient refusing to participate
  • Patient with difficulties in understanding the French language.
  • Protected persons referred to in articles L.1121-6 to L.1121-8 of the public health code
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
30 participants (actual)
Patient registry
No

Interventions

  • OtherFRAnçaise du PEYronie's Disease QUESTionnaire

    Complete an online FRAnçaise du PEYronie's Disease QUESTionnaire

06

What researchers measure

Primary outcomes

  1. Rate of responses

    Response rate to the online questionnaire.

    Time frame: Day 0

07

Study locations

1 site
  • Toulouse Hospital
    Toulouse, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 27, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05768867
Lead sponsor
University Hospital, Toulouse
Responsible party
Sponsor
First posted
Mar 14, 2023
Start date
Mar 6, 2023
Primary completion
May 22, 2023
Completion
May 22, 2023
Last update
Aug 27, 2024

Study contacts

Eric Huyghe, MD
principal investigator · University Hospital, Toulouse

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion